SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-21-014596
Filing Date
2021-04-27
Accepted
2021-04-27 17:00:36
Documents
3
Period of Report
2021-06-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A nc10020690x1_def14a.htm DEF 14A 622154
2 nc10020690x1_proxycardsx3.jpg GRAPHIC 565304
3 nc10020690x1_proxycardsx4.jpg GRAPHIC 453622
  Complete submission text file 0001140361-21-014596.txt   2026169
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36500 | Film No.: 21859813
SIC: 2834 Pharmaceutical Preparations